NeurologyLive® Friday 5 — July 4, 2025

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Most Impactful Neurology Trial Readouts From Early 2025

Overviewing the major clinical trial readouts in neurology from the first half of 2025, with data that could potentially reshape patient care.

2: Studying an Oral Nighttime Therapy in Mild to Severe Obstructive Sleep Apnea: The LunAIRo Trial

Following positive phase 3 findings, Apnimed plans to submit a new drug application to the FDA in early 2026 for its lead candidate AD109 as a potential treatment of obstructive sleep apnea.

3: Integrating Experiential and Holistic Approaches in Parkinson Disease Management: Anissa Mitchell, LCSW

The chief program officer at PMD Alliance discussed the value of combining experiential learning and holistic care strategies to support advanced therapeutics in Parkinson disease. [WATCH TIME: 4 minutes]

4: Improving the Management of Parkinson Through Psychological Interventions: Marcia Pasqualini, PhD

The professor of psychology at Avila University discussed how cognitive behavioral therapy and social support can help to improve quality of life for individuals with Parkinson disease. [WATCH TIME: 4 minutes]

5: Incorporating Palliative Care Principles into Movement Disorder Management: Jennifer Corcoran, MD

The movement disorder neurologist at University of Rochester Medical Center outlined a 5-pillar model that emphasized holistic care, patient-centered communication, and proactive support in movement disorders. [WATCH TIME: 5 minutes]